ECG / EKG in New Jersey

iMedrix Diagnostics Corp. is a medical device company headquartered in Northern New Jersey specializing in mobile cardiac care solutions. The company develops and markets KardioScreen™, a US FDA 510(k)-cleared, medical-grade mobile 12/6-lead ECG system that enables real-time cardiac monitoring and diagnosis. KardioScreen™ is cloud-connected, fully digital, and designed for bedside and remote monitoring applications, allowing clinicians to diagnose and manage cardiac conditions within minutes. The platform serves hospitals, clinics, and care providers seeking portable, economical alternatives to traditional fixed ECG systems. iMedrix targets both acute care settings and remote/home-based monitoring environments. The company emphasizes patient-centric design, regulatory compliance (FDA 510(k) clearance), and accessibility of cardiac diagnostics through innovative digital technology.

VectraCor designs and manufactures portable diagnostic medical devices that enable primary care, urgent care, and telemedicine environments to perform cardiac and pulmonary testing. The company specializes in ECG systems, Holter monitoring, and spirometry platforms that integrate with standard tablets and laptops, reducing infrastructure costs while maintaining clinical-grade diagnostics. The VectraplexECG system uses patented 5-electrode technology to derive 15–22 lead ECG traces and detect changes suggestive of acute coronary events via the proprietary Cardiac Electrical Biomarker (CEB®). The V300 Holter monitor provides continuous ambulatory cardiac monitoring with cloud-based data transfer and EMR integration. The Orbit™ Spirometer delivers pulmonary function testing with mobile deployment. All devices are FDA-cleared, CE-marked, and manufactured under ISO 13485 certification. VectraCor products emphasize durable, portable design for point-of-care diagnostics and remote monitoring workflows, with integrated EMR connectivity to major health systems and email-based report distribution.